Latest Breaking News On - Pharma market regional - Page 1 : comparemela.com

Global Healthcare and Pharma Market to Grow by $10 2 trillion and $1 5 trillion, respectively, in 2023

Global Healthcare and Pharma Market to Grow by $10.2 trillion and $1.5 trillion, respectively, in 2023 – GlobalData Plc

Republic ofSouth africaSaudi arabiaUnited kingdomMark jephcottResearch newswireGlobaldata plcSee campaignJapan cabinet officeUs congressGlobal healthcarePharma marketInflation reductionPharma market regionalCabinet officeVaccine taskforce

Global Healthcare and Pharma Market to Grow by $10 2 trillion and $1 5 trillion, respectively, in 2023

Global Healthcare and Pharma Market to Grow by $10 2 trillion and $1 5 trillion, respectively, in 2023
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

Saudi arabiaRepublic ofUnited kingdomSouth africaMark jephcottJapan cabinet officeResearch newswireGlobaldata plcSee campaignUs congressGlobal healthcarePharma marketInflation reductionPharma market regionalCabinet officeVaccine taskforce

Global Ai In Pharma Market Report 2021: Long-term Forecast to 2025 & 2030 Featuring Novartis, IBM Watson, Microsoft, Merck, GNS Healthcare , Google, AstraZeneca, Atomwise, Exscientia, and Cyclica

Share this article Share this article ResearchAndMarkets.com s offering. This report focuses on Ai in pharma market which is experiencing strong growth. The report gives a guide to the ai in pharma market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic. Major players in the artificial intelligence (AI) in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise, Inc., Exscientia, and Cyclica. The global AI in pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 at a compound annual growth rate (CAGR) of 39%.

United statesUnited kingdomSouth koreaBristol myers squibbLaura woodXtalpi incCloud pharmaceuticals incRecursion pharmaceuticals incMicrosoft corporationOffice hours callSegmentation technologyE st office hours callClinical trial researchAtomwise incPharma global market reportWestern europe